MedPath

Hannover Medical School

Hannover Medical School logo
🇩🇪Germany
Ownership
Private
Established
1965-01-01
Employees
5K
Market Cap
-
Website
http://www.mh-hannover.de

Clinical Trials

231

Active:36
Completed:89

Trial Phases

5 Phases

Phase 1:31
Phase 2:21
Phase 3:16
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (144 trials with phase data)• Click on a phase to view related trials

Not Applicable
59 (41.0%)
Phase 1
31 (21.5%)
Phase 2
21 (14.6%)
Phase 3
16 (11.1%)
Phase 4
16 (11.1%)
phase_1_2
1 (0.7%)

T-cell Therapy in Patients With PML

Phase 2
Not yet recruiting
Conditions
Progressive Multifocal Leucoencephalopathy (PML)
Interventions
Drug: Application of T-lymphocytes
First Posted Date
2025-05-25
Last Posted Date
2025-05-25
Lead Sponsor
Hannover Medical School
Target Recruit Count
23
Registration Number
NCT06990087

Data Analysis and Evaluation of the Incidence of Life-threatening Ventricular Arrhythmias in Patients with Newly Diagnosed Cardiomyopathies of NICM or MI/CAD Origin PROTECTED from SCD by a WCD

Completed
Conditions
Cardiomyopathy (Ischemic or Non-Ischemic)
First Posted Date
2025-03-19
Last Posted Date
2025-03-19
Lead Sponsor
Hannover Medical School
Target Recruit Count
19598
Registration Number
NCT06883383
Locations
🇩🇪

Hannover Medical School, Hannover, Germany

Observational Study on the Clinical Use of Ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

Recruiting
Conditions
Lung Transplantation
First Posted Date
2025-01-28
Last Posted Date
2025-01-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
20
Registration Number
NCT06795516
Locations
🇩🇪

Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover, Germany

Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia

Not Applicable
Recruiting
Conditions
Schizophrenia Patients
First Posted Date
2024-12-18
Last Posted Date
2025-07-20
Lead Sponsor
Hannover Medical School
Target Recruit Count
60
Registration Number
NCT06740747
Locations
🇩🇪

Hannover Medical School, Hannover, Niedersachsen, Germany

The "Seamless" Patient:From Preoperative Preparation to Postoperative Rehabilitation

Not Applicable
Recruiting
Conditions
Heart Failure
First Posted Date
2024-11-21
Last Posted Date
2024-11-21
Lead Sponsor
Hannover Medical School
Target Recruit Count
300
Registration Number
NCT06699446
Locations
🇩🇪

Medical School Hanover, Hannover, Lower Saxony, Germany

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 39
  • Next

News

Viromed's Cold Plasma Technology Demonstrates Potential to Prevent 6,000 Deaths Annually from Ventilator-Associated Pneumonia

Preclinical study by Hannover Medical School shows Viromed's cold plasma technology could prevent up to 6,000 deaths per year in Germany from ventilator-associated pneumonia.

Viromed Medical AG Advances Cold Plasma Technology as "Digital Antibiotic" for Ventilator-Associated Pneumonia Prevention

Viromed Medical AG is advancing research on cold plasma technology as a potential "digital antibiotic" for preventing ventilator-associated pneumonia (VAP), which affects 23-36% of mechanically ventilated patients in Germany with a mortality rate of 10-13%.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.